Literature DB >> 21298675

Characterization of biofilms in different clinical M serotypes of Streptococcus pyogenes.

Ramalingam Thenmozhi1, Kannan Balaji, Rajesh Kumar, Toleti Subba Rao, Shunmugiah Karutha Pandian.   

Abstract

Streptococcus pyogenes is a notorious human pathogen responsible for a wide array of infections. The ability of S. pyogenes to form biofilms is an innate property during the pathogenesis of invasive infections. From the eleven M serotypes tested: M56, M74, M100, M65, M89 and st38 formed dense biofilms in 48 h. The present study is the first of its kind to report about the biofilm formation in the serotypes M56, M65 M74 M100 and st38. XTT reduction assay of the biofilms showed decreased metabolic activity with increase in incubation time. The surface architecture of the biofilms when observed by scanning electron microscopy (SEM) revealed the microcolony formation. Confocal laser scanning microscopy (CLSM) was used to compare the surface topography and thickness of biofilms between the biofilm formers with and without the addition of glucose. Interestingly a non-biofilm former (st2147) was induced to form biofilms with the addition of glucose. On correlating the drug (erythromycin) resistance of the various M serotypes with their biofilm forming ability we noticed that erythromycin sensitive strains were found to be good biofilm formers. We also noticed that biofilm formation in S. pyogenes is independent of sil gene.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21298675     DOI: 10.1002/jobm.201000006

Source DB:  PubMed          Journal:  J Basic Microbiol        ISSN: 0233-111X            Impact factor:   2.281


  6 in total

1.  Two group A streptococcal peptide pheromones act through opposing Rgg regulators to control biofilm development.

Authors:  Jennifer C Chang; Breah LaSarre; Juan C Jimenez; Chaitanya Aggarwal; Michael J Federle
Journal:  PLoS Pathog       Date:  2011-08-04       Impact factor: 6.823

2.  covR Mediated Antibiofilm Activity of 3-Furancarboxaldehyde Increases the Virulence of Group A Streptococcus.

Authors:  Ganapathy Ashwinkumar Subramenium; Dharmaprakash Viszwapriya; Prasanth Mani Iyer; Krishnaswamy Balamurugan; Shunmugiah Karutha Pandian
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

3.  Current Understanding of Group A Streptococcal Biofilms.

Authors:  Heema K N Vyas; Emma-Jayne Proctor; Jason McArthur; Jody Gorman; Martina Sanderson-Smith
Journal:  Curr Drug Targets       Date:  2019       Impact factor: 3.465

4.  Streptococcus pyogenes Capsule Promotes Microcolony-Independent Biofilm Formation.

Authors:  Artur Matysik; Kimberly A Kline
Journal:  J Bacteriol       Date:  2019-08-22       Impact factor: 3.490

5.  Consistent Biofilm Formation by Streptococcus pyogenes emm 1 Isolated From Patients With Necrotizing Soft Tissue Infections.

Authors:  Dag Harald Skutlaberg; Harald G Wiker; Haima Mylvaganam; Anna Norrby-Teglund; Steinar Skrede
Journal:  Front Microbiol       Date:  2022-02-18       Impact factor: 5.640

6.  Effect of subinhibitory concentrations of fluoroquinolones on biofilm production by clinical isolates of Streptococcus pyogenes.

Authors:  Kannan Balaji; Ramalingam Thenmozhi; Shunmugiah Karutha Pandian
Journal:  Indian J Med Res       Date:  2013-05       Impact factor: 2.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.